Reserpine

利血平

Report date: 2023/03/09 20:00:36
NME

Base Information

Drug NameReserpine
Drug Alias Namereserpina塞尔芬蛇根碱reserpinum利舍平 +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSynaptic vesicular amine transporter inhibitors
TargetsSynaptic vesicular amine transporter
Therapy Area/IndicationsCocaine-Related DisordersSubstance-Related DisordersRaynaud Disease +[4] 
Global Approved IndicationsHypertension
Approved Indications in ChinaHypertension
Original Approved Country/TerritoryCanada
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesHarbin Taihua Pharmaceutical Co Ltd
Inactive CompaniesNovopharm LtdNational Institute On Drug AbuseUniversity Of Alabama At Birmingham
Active IndicationsRaynaud DiseaseHypertension
Inactive IndicationsCocaine-Related DisordersSubstance-Related Disorders

Other Information

ATC CodeC02AA02
Related LinksWikipediaDrugBankKEGG